Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations

NCT01246401 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT01246401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01246401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
Lead sponsor
Yale University
Phase
Phase 1/2
Overall status
Completed
Start date
March 31, 2011
Completion date
July 31, 2016
Enrollment
151 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

aids, drug dependence, hiv, opioid dependence